BackCan-Fite Biopharma Overview

Can-Fite Biopharma Current Cash

Latest current cash for CANF: $3M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$2.98M
↓ 53.75% YoYΔ $-3.47M vs prior year quarter

Peer trimmed avg / median

Loading

Can-Fite Biopharma Current Cash History

Loading

Can-Fite Biopharma vs. peers: Current Cash Comparison

Loading

Can-Fite Biopharma Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Can-Fite Biopharma (CANF) FAQ

The latest current cash for CANF is $3M as of June 2026. That compares with $6.5M in the prior-year period — down 53.7% year over year. Investors often review this figure alongside Can-Fite Biopharma's historical trend and sector peers before judging valuation or financial health.

Over the past year, CANF's current cash moved from $6.5M to $3M — a 53.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Can-Fite Biopharma's operating scale or balance-sheet position.

A current cash figure of $3M for CANF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CANF's current cash ($3M), review year-over-year change from $6.5M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Can-Fite Biopharma's current cash against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.